AI medtech commercial intelligence market to hit $7.17 billion by 2030

The global AI-powered medtech commercial intelligence market is projected to grow from $2.66 billion in 2025 to $7.17 billion by 2030, driven by healthcare data growth, predictive analytics and cloud-based tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest in the coming years.

Why it matters: - Medtech companies are leaning harder on AI to turn growing healthcare data volumes into commercial decisions. - The shift could improve sales targeting, competitive tracking and market planning across the medical technology sector. - The market’s projected 21.8% CAGR through 2030 signals sustained demand for automated intelligence tools in healthcare commercialization.

What happened: - The Business Research Company released its Global AI-Powered Medtech Commercial Intelligence Global Market Report 2026 on Sept. 15, 2026. - The report projects the market will rise from $2.66 billion in 2025 to $3.26 billion in 2026. - The report forecasts the market will reach $7.17 billion by 2030. - The forecast implies a 21.8% CAGR from 2026 to 2030. - North America led the market in 2025. - Asia-Pacific is forecast to be the fastest-growing region in the coming years.

The details: - AI-powered medtech commercial intelligence uses AI tools to collect, analyze and interpret business and market data in the medical technology sector. - The approach helps companies assess market dynamics, customer behavior, competition, sales effectiveness and growth opportunities. - The recent growth period was fueled by broader adoption of healthcare data analytics, rising demand for competitive intelligence tools, expansion of digital healthcare, stronger medical device commercialization and more focus on optimizing sales territories. - The long-term outlook is driven by predictive analytics platforms, real-time healthcare data streams, personalized commercialization strategies, cloud-based commercial intelligence services and automated decision intelligence. - Key trends include predictive sales intelligence, real-time market monitoring, provider-centric commercial analytics, blending clinical and commercial datasets, and data-driven sales benchmarking. - The report says healthcare data volume is rising because of electronic health records and other digital sources, creating more demand for AI tools that can extract actionable insights. - In July 2025, the US Office of the National Coordinator for Health IT reported that over 75% of Americans had online access to their medical records in 2024, including 86% of cancer patients and 76% who reviewed their records at least once in the prior year.

Between the lines: - The market growth reflects a broader healthcare shift from raw data collection to decision-making platforms that can act on that data in near real time. - Medtech vendors that can combine clinical and commercial data may gain an edge as buyers look for tools that improve targeting and performance measurement. - Regional leadership in North America suggests a mature base of healthcare digitization, while Asia-Pacific’s growth outlook points to faster adoption in expanding healthcare markets.

What's next: - The report expects continued adoption of predictive and real-time analytics across medtech commercial teams. - More cloud-based and automated commercial intelligence platforms are likely to enter the market as providers seek faster decision support. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspot infographics, and updated trend analysis. - The company also made the full report and a free sample available online via the report page and a sample request.

The bottom line: - AI-powered medtech commercial intelligence is moving from niche capability to core commercial infrastructure, with double-digit growth expected through the end of the decade.